Cargando…

Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China

BACKGROUND: A novel variant of SARS-CoV-2, the Delta variant of concern (VOC, also known as lineage B.1.617.2), is fast becoming the dominant strain globally. We reported the epidemiological, viral, and clinical characteristics of hospitalized patients infected with the Delta VOC during the local ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yaping, Chen, Ruchong, Hu, Fengyu, Lan, Yun, Yang, Zhaowei, Zhan, Chen, Shi, Jingrong, Deng, Xizi, Jiang, Mei, Zhong, Shuxin, Liao, Baolin, Deng, Kai, Tang, Jingyan, Guo, Liliangzi, Jiang, Mengling, Fan, Qinghong, Li, Meiyu, Liu, Jinxin, Shi, Yaling, Deng, Xilong, Xiao, Xincai, Kang, Min, Li, Yan, Guan, Weijie, Li, Yimin, Li, Shiyue, Li, Feng, Zhong, Nanshan, Tang, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435265/
https://www.ncbi.nlm.nih.gov/pubmed/34541481
http://dx.doi.org/10.1016/j.eclinm.2021.101129
_version_ 1783751756774113280
author Wang, Yaping
Chen, Ruchong
Hu, Fengyu
Lan, Yun
Yang, Zhaowei
Zhan, Chen
Shi, Jingrong
Deng, Xizi
Jiang, Mei
Zhong, Shuxin
Liao, Baolin
Deng, Kai
Tang, Jingyan
Guo, Liliangzi
Jiang, Mengling
Fan, Qinghong
Li, Meiyu
Liu, Jinxin
Shi, Yaling
Deng, Xilong
Xiao, Xincai
Kang, Min
Li, Yan
Guan, Weijie
Li, Yimin
Li, Shiyue
Li, Feng
Zhong, Nanshan
Tang, Xiaoping
author_facet Wang, Yaping
Chen, Ruchong
Hu, Fengyu
Lan, Yun
Yang, Zhaowei
Zhan, Chen
Shi, Jingrong
Deng, Xizi
Jiang, Mei
Zhong, Shuxin
Liao, Baolin
Deng, Kai
Tang, Jingyan
Guo, Liliangzi
Jiang, Mengling
Fan, Qinghong
Li, Meiyu
Liu, Jinxin
Shi, Yaling
Deng, Xilong
Xiao, Xincai
Kang, Min
Li, Yan
Guan, Weijie
Li, Yimin
Li, Shiyue
Li, Feng
Zhong, Nanshan
Tang, Xiaoping
author_sort Wang, Yaping
collection PubMed
description BACKGROUND: A novel variant of SARS-CoV-2, the Delta variant of concern (VOC, also known as lineage B.1.617.2), is fast becoming the dominant strain globally. We reported the epidemiological, viral, and clinical characteristics of hospitalized patients infected with the Delta VOC during the local outbreak in Guangzhou, China. METHODS: We extracted the epidemiological and clinical information pertaining to the 159 cases infected with the Delta VOC across seven transmission generations between May 21 and June 18, 2021. The whole chain of the Delta VOC transmission was described. Kinetics of viral load and clinical characteristics were compared with a cohort of wild-type infection in 2020 admitted to the Guangzhou Eighth People's Hospital. FINDINGS: There were four transmission generations within the first ten days. The Delta VOC yielded a significantly shorter incubation period (4.0 vs. 6.0 days), higher viral load (20.6 vs. 34.0, cycle threshold of the ORF1a/b gene), and a longer duration of viral shedding in pharyngeal swab samples (14.0 vs. 8.0 days) compared with the wild-type strain. In cases with critical illness, the proportion of patients over the age of 60 was higher in the Delta VOC group than in the wild-type strain (100.0% vs. 69.2%, p = 0.03). The Delta VOC had a higher risk than wild-type infection in deterioration to critical status (hazards ratio 2.98 [95%CI 1.29-6.86]; p = 0.01). INTERPRETATION: Infection with the Delta VOC is characterized by markedly increased transmissibility, viral loads and risk of disease progression compared with the wild-type strain, calling for more intensive prevention and control measures to contain future outbreaks. FUNDING: National Grand Program, National Natural Science Foundation of China, Guangdong Provincial Department of Science and Technology, Guangzhou Laboratory
format Online
Article
Text
id pubmed-8435265
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84352652021-09-13 Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China Wang, Yaping Chen, Ruchong Hu, Fengyu Lan, Yun Yang, Zhaowei Zhan, Chen Shi, Jingrong Deng, Xizi Jiang, Mei Zhong, Shuxin Liao, Baolin Deng, Kai Tang, Jingyan Guo, Liliangzi Jiang, Mengling Fan, Qinghong Li, Meiyu Liu, Jinxin Shi, Yaling Deng, Xilong Xiao, Xincai Kang, Min Li, Yan Guan, Weijie Li, Yimin Li, Shiyue Li, Feng Zhong, Nanshan Tang, Xiaoping EClinicalMedicine Research Paper BACKGROUND: A novel variant of SARS-CoV-2, the Delta variant of concern (VOC, also known as lineage B.1.617.2), is fast becoming the dominant strain globally. We reported the epidemiological, viral, and clinical characteristics of hospitalized patients infected with the Delta VOC during the local outbreak in Guangzhou, China. METHODS: We extracted the epidemiological and clinical information pertaining to the 159 cases infected with the Delta VOC across seven transmission generations between May 21 and June 18, 2021. The whole chain of the Delta VOC transmission was described. Kinetics of viral load and clinical characteristics were compared with a cohort of wild-type infection in 2020 admitted to the Guangzhou Eighth People's Hospital. FINDINGS: There were four transmission generations within the first ten days. The Delta VOC yielded a significantly shorter incubation period (4.0 vs. 6.0 days), higher viral load (20.6 vs. 34.0, cycle threshold of the ORF1a/b gene), and a longer duration of viral shedding in pharyngeal swab samples (14.0 vs. 8.0 days) compared with the wild-type strain. In cases with critical illness, the proportion of patients over the age of 60 was higher in the Delta VOC group than in the wild-type strain (100.0% vs. 69.2%, p = 0.03). The Delta VOC had a higher risk than wild-type infection in deterioration to critical status (hazards ratio 2.98 [95%CI 1.29-6.86]; p = 0.01). INTERPRETATION: Infection with the Delta VOC is characterized by markedly increased transmissibility, viral loads and risk of disease progression compared with the wild-type strain, calling for more intensive prevention and control measures to contain future outbreaks. FUNDING: National Grand Program, National Natural Science Foundation of China, Guangdong Provincial Department of Science and Technology, Guangzhou Laboratory Elsevier 2021-09-12 /pmc/articles/PMC8435265/ /pubmed/34541481 http://dx.doi.org/10.1016/j.eclinm.2021.101129 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Wang, Yaping
Chen, Ruchong
Hu, Fengyu
Lan, Yun
Yang, Zhaowei
Zhan, Chen
Shi, Jingrong
Deng, Xizi
Jiang, Mei
Zhong, Shuxin
Liao, Baolin
Deng, Kai
Tang, Jingyan
Guo, Liliangzi
Jiang, Mengling
Fan, Qinghong
Li, Meiyu
Liu, Jinxin
Shi, Yaling
Deng, Xilong
Xiao, Xincai
Kang, Min
Li, Yan
Guan, Weijie
Li, Yimin
Li, Shiyue
Li, Feng
Zhong, Nanshan
Tang, Xiaoping
Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China
title Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China
title_full Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China
title_fullStr Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China
title_full_unstemmed Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China
title_short Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China
title_sort transmission, viral kinetics and clinical characteristics of the emergent sars-cov-2 delta voc in guangzhou, china
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435265/
https://www.ncbi.nlm.nih.gov/pubmed/34541481
http://dx.doi.org/10.1016/j.eclinm.2021.101129
work_keys_str_mv AT wangyaping transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT chenruchong transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT hufengyu transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT lanyun transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT yangzhaowei transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT zhanchen transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT shijingrong transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT dengxizi transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT jiangmei transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT zhongshuxin transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT liaobaolin transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT dengkai transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT tangjingyan transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT guoliliangzi transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT jiangmengling transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT fanqinghong transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT limeiyu transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT liujinxin transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT shiyaling transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT dengxilong transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT xiaoxincai transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT kangmin transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT liyan transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT guanweijie transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT liyimin transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT lishiyue transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT lifeng transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT zhongnanshan transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina
AT tangxiaoping transmissionviralkineticsandclinicalcharacteristicsoftheemergentsarscov2deltavocinguangzhouchina